The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.

Despite an increase in the conversion factor, slashed payments elsewhere could amount to “death by a thousand paper cuts.” ...

The “hypothesis-generating” results show that the technology might improve use of preventive therapies, especially in women.